title: How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention.
abstract: Recent research has demonstrated how antiretrovirals (ARVs) could be effective in the prevention of sexually transmitted HIV. We review research on the acceptability of oral pre-exposure prophylaxis (PrEP) and treatment as prevention (TasP) for HIV prevention amongst potential users. We consider with whom, where and in what context this research has been conducted, how acceptability has been approached, and what research gaps remain. Findings from 33 studies show a lack of TasP research, PrEP studies which have focused largely on men who have sex with men (MSM) in a US context, and varied measures of acceptability. In order to identify when, where and for whom PrEP and TasP would be most appropriate and effective, research is needed in five areas: acceptability of TasP to people living with HIV; motivation for PrEP use and adherence; current perceptions and management of risk; the impact of broader social and structural factors; and consistent definition and operationalisation of acceptability which moves beyond adherence.
authors.affiliation: MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, 4 Lilybank Gardens, Glasgow, G12 8RZ, UK, i.young@sphsu.mrc.ac.uk.
authors.forename: Ingrid
authors.initials: I
authors.lastname: Young
authors.forename: Lisa
authors.initials: L
authors.lastname: McDaid
mesh_terms: D000328:Adult; D044966:Anti-Retroviral Agents / Q000008:administration & dosage*; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D008297:Male; D010342:Patient Acceptance of Health Care / Q000523:psychology*; D012725:Sexual Behavior
chemical_list: D044966:Anti-Retroviral Agents
references.citation: PLoS Med. 2007 Oct 16;4(10):e296
references.pmid: 17941714
references.citation: PLoS One. 2012;7(3):e32329
references.pmid: 22479320
references.citation: BMC Infect Dis. 2013 May 14;13:217
references.pmid: 23672424
references.citation: MMWR Morb Mortal Wkly Rep. 2011 Jan 28;60(3):65-8
references.pmid: 21270743
references.citation: Soc Sci Med. 2012 Nov;75(9):1555-61
references.pmid: 22495513
references.citation: AIDS Educ Prev. 2012 Oct;24(5):408-21
references.pmid: 23016502
references.citation: PLoS One. 2012;7(1):e28238
references.pmid: 22247757
references.citation: Sex Transm Infect. 2013 May;89(3):207-11
references.pmid: 23015689
references.citation: AIDS Patient Care STDS. 2010 Dec;24(12):747-50
references.pmid: 21091230
references.citation: PLoS One. 2012;7(11):e50061
references.pmid: 23166819
references.citation: AIDS Care. 2008 Jan;20(1):106-15
references.pmid: 18278621
references.citation: AIDS. 2011 Jan 28;25(3):291-3
references.pmid: 20962615
references.citation: AIDS Patient Care STDS. 2010 Nov;24(11):689-91
references.pmid: 20863247
references.citation: MMWR Morb Mortal Wkly Rep. 2012 Aug 10;61(31):586-9
references.pmid: 22874836
references.citation: AIDS Care. 2011 Sep;23(9):1136-45
references.pmid: 21476147
references.citation: Implement Sci. 2012 Nov 26;7:116
references.pmid: 23181780
references.citation: J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):447-56
references.pmid: 24135734
references.citation: PLoS One. 2012;7(3):e33119
references.pmid: 22470438
references.citation: Curr HIV/AIDS Rep. 2010 Nov;7(4):201-9
references.pmid: 20809218
references.citation: AIDS Behav. 2012 Jul;16(5):1243-59
references.pmid: 22460228
references.citation: AIDS Behav. 2013 Jul;17(6):2162-72
references.pmid: 23080358
references.citation: J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):77-83
references.pmid: 19295337
references.citation: Int J STD AIDS. 2012 Jan;23(1):1-4
references.pmid: 22362679
references.citation: Curr HIV Res. 2011 Sep;9(6):367-82
references.pmid: 21999772
references.citation: Expert Rev Anti Infect Ther. 2011 Apr;9(4):431-42
references.pmid: 21504400
references.citation: AIDS Patient Care STDS. 2011 Jun;25(6):365-70
references.pmid: 21470046
references.citation: Soc Sci Med. 2003 Jul;57(1):1-12
references.pmid: 12753812
references.citation: AIDS Care. 2012;24(4):468-77
references.pmid: 22085083
references.citation: HIV Med. 2010 Sep;11(8):502-9
references.pmid: 20201976
references.citation: Am J Public Health. 2012 May;102(5):789-99
references.pmid: 22493997
references.citation: N Engl J Med. 2012 Aug 23;367(8):685-7
references.pmid: 22809362
references.citation: HIV Med. 2010 Apr;11(4):282-8
references.pmid: 20015220
references.citation: Sci Transl Med. 2012 Sep 12;4(151):151ra125
references.pmid: 22972843
references.citation: Health Educ Res. 2011 Jun;26(3):381-92
references.pmid: 21536716
references.citation: Lancet. 2008 Aug 16;372(9638):585-99
references.pmid: 18687456
references.citation: Int J STD AIDS. 2011 Dec;22(12):738-41
references.pmid: 22174057
references.citation: Sex Transm Dis. 2008 Dec;35(12):1002-8
references.pmid: 19051397
references.citation: Curr Opin HIV AIDS. 2012 Nov;7(6):542-8
references.pmid: 22964887
references.citation: AIDS Care. 2012;24(8):1013-9
references.pmid: 22519656
references.citation: J Int AIDS Soc. 2010 Apr 14;13:13
references.pmid: 20398261
references.citation: Sex Transm Infect. 2012 Jun;88(4):258-63
references.pmid: 22290327
references.citation: AIDS Care. 2010 Dec;22(12):1487-92
references.pmid: 20845111
references.citation: J Womens Health (Larchmt). 2010 Apr;19(4):791-8
references.pmid: 20210540
references.citation: Curr HIV/AIDS Rep. 2013 Mar;10(1):79-88
references.pmid: 23239272
references.citation: Curr Opin HIV AIDS. 2012 Mar;7(2):99-105
references.pmid: 22227585
references.citation: JAMA. 2004 Jul 14;292(2):224-36
references.pmid: 15249572
references.citation: HIV Med. 2013 May;14(5):259-62
references.pmid: 23489936
references.citation: PLoS One. 2012;7(4):e33103
references.pmid: 22511916
references.citation: AIDS Behav. 2012 Oct;16(7):1853-61
references.pmid: 22538373
references.citation: Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440
references.pmid: 20238370
references.citation: J Acquir Immune Defic Syndr. 2010 Oct;55(2):e14-6
references.pmid: 20859085
references.citation: Cochrane Database Syst Rev. 2012 Jul 11;(7):CD007189
references.pmid: 22786505
references.citation: J Acquir Immune Defic Syndr. 2003 Apr 15;32(5):545-50
references.pmid: 12679708
references.citation: Int J STD AIDS. 2011 May;22(5):256-62
references.pmid: 21571973
references.citation: J Acquir Immune Defic Syndr. 2010 Aug;54(5):548-55
references.pmid: 20512046
references.citation: Euro Surveill. 2011 Dec 01;16(48):
references.pmid: 22172298
references.citation: Curr Opin HIV AIDS. 2012 Nov;7(6):534-41
references.pmid: 23032737
references.citation: HIV Med. 2012 Sep;13 Suppl 2:1-85
references.pmid: 22830364
references.citation: AIDS Patient Care STDS. 2012 Feb;26(2):87-94
references.pmid: 22149764
references.citation: J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):463-8
references.pmid: 22267018
references.citation: AIDS Behav. 2013 Jul;17(6):2156-61
references.pmid: 23001412
references.citation: AIDS Behav. 2013 Feb;17(2):737-47
references.pmid: 23065145